{"id":"W3114561183","doi":"10.1016/j.ahj.2020.12.008","title":"Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University of British Columbia","funders":"Janssen Research and Development; Relypsa; NxStage; Janssen Scientific Affairs; Janssen Pharmaceuticals; Gilead Sciences; Novo Nordisk; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Canagliflozin; Medicine; Heart failure; Type 2 diabetes; Kidney disease; Diabetes mellitus; Nephropathy; Internal medicine; Placebo; Clinical trial; Cardiology; Intensive care medicine; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002889847,0.0001345542,0.0006451033,0.00006446373,0.00003515157,0.00001102118,0.00005775679,0.00001351996,0.000005321108],"category_scores_gemma":[0.0008618366,0.0000832431,0.00009848658,0.0001833796,0.000172246,0.00005244899,0.00004877202,0.0001462666,0.000001143629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001697178,"about_ca_system_score_gemma":0.0003134547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005755373,"about_ca_topic_score_gemma":0.00005203587,"domain_scores_codex":[0.9987791,0.0001635371,0.0002892489,0.0002182461,0.0003134,0.000236476],"domain_scores_gemma":[0.9987965,0.0003880899,0.0001108219,0.0001965334,0.00003683927,0.0004712147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04107378,0.0003415431,0.9136399,0.0002269752,0.00246051,0.0001213021,0.00205984,0.0002662601,0.004625751,0.000007120908,0.02527016,0.00990687],"study_design_scores_gemma":[0.03793822,0.01044251,0.9107291,0.001365951,0.001635522,0.000002226178,0.0005517406,0.0001500606,0.001316605,0.000005637848,0.03562466,0.0002378303],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879315,0.002184944,0.000004330203,0.009165349,0.00008676838,0.0005908837,0.00001358665,0.000006966259,0.00001564417],"genre_scores_gemma":[0.9971171,0.0002237658,0.0003212251,0.002173277,0.0001153555,0.00001391626,0.000003614581,0.00001292714,0.00001878868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0103545,"threshold_uncertainty_score":0.3394555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02275117013111997,"score_gpt":0.2595466790822277,"score_spread":0.2367955089511078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}